New Clinical Trials Open for Sarcomas and Solid Tumors
![](https://oncologytrials.wustl.edu/wp-content/uploads/2024/07/july_email_headline_img.jpg)
Two exciting early phase clinical trials are underway at Siteman Cancer Center, based at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, that leverage novel classes of drugs and exploit how proteins can be targeted and/or removed to stop uncontrolled cell division that occurs in sarcomas and solid tumors. For BRAF B600 […]
Washington University School of Medicine in St. Louis Awarded $10.9 Million SPORE Grant for Pancreas Cancer
![](https://oncologytrials.wustl.edu/wp-content/uploads/2023/10/PacreaticTumorDeNardo-1024x683.jpg)
New Clinical Trials Set for Pancreatic Ductal Adenocarcinoma Clinical researchers at Washington University School of Medicine in St. Louis have been awarded a Specialized Programs of Research Excellence (SPORE) grant from the National Cancer Institute (NCI) to continue clinical trials and research aimed at advancing pancreatic cancer care. Awarded in July 2023, it marks the […]
Personalized cancer vaccines for breast, pancreatic cancers show promise
![](https://oncologytrials.wustl.edu/wp-content/uploads/2021/07/Cancer-Vaccine-1024x683.jpeg)
Researchers at Washington University School of Medicine in St. Louis have shown that personalized cancer vaccines made using DNA…